Leon O. Moulder Jr.
Director at Dianthus Therapeutics; Chief Executive Officer at Zenas BioPharma; Director at Zai Lab. Based in Cambridge, Massachusetts.
- Rank
- 1169th of 14,452
- Companies held
- 3
- Largest holding
- DNTH, 88.4% of total
- Latest SEC filing
- Jun 17, 2026
- Listed but not counted
- $194M
What the $138M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Dianthus Therapeutics DNTH Common Stock | Indirectly (see filing footnote) | 1,436,745 | $84.83 | $122M | 88.4% | Form 4, Jan 22, 2024 |
| Zenas BioPharma ZBIO Common Stock | Directly | 423,155 | $25.04 | $10.6M | 7.7% | Form 4, May 18, 2026 |
| Zenas BioPharma ZBIO Common Stock | Through Leon O. Moulder, Jr. Revocable Trust | 96,928 | $25.04 | $2.4M | 1.8% | Form 4, May 18, 2026 |
| Zai Lab ZLAB American Depositary Shares | Directly | 94,973 | $21.92 | $2.1M | 1.5% | Form 4, Jun 17, 2026 |
| Zenas BioPharma ZBIO Common Stock | Indirectly (see filing footnote) | 36,928 | $25.04 | $925K | 0.7% | Form 4, Jan 7, 2026 |
Share counts are the amounts Leon O. Moulder Jr. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Leon O. Moulder Jr.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Dianthus Therapeutics DNTH Common Stock | Through Tellus BioVentures, LLC Held by a company or fund the insider manages | 1,270,078 | $84.83 | $108M | — | Form 3, Sep 11, 2023 |
| Zenas BioPharma ZBIO Common Stock | Through Tellus BioVentures LLC Held by a company or fund the insider manages | 1,786,039 | $25.04 | $44.7M | — | Form 4, May 18, 2026 |
| Zenas BioPharma ZBIO Common Stock | Through Tellus BioVentures LLC Held by a company or fund the insider manages | 1,672,039 | $25.04 | $41.9M | — | Form 4, Oct 7, 2025 |
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 18, 2026 | Bought | ZBIO | 60,000 | $16.88 | $1.0M | View |
| Apr 29, 2026 | Bought | ZBIO | 35,000 | $17.62 | $617K | View |
| Apr 28, 2026 | Bought | ZBIO | 25,000 | $18.02 | $451K | View |
| Mar 31, 2026 | Bought | ZBIO | 34,000 | $19.31 | $657K | View |
| Mar 30, 2026 | Bought | ZBIO | 20,000 | $18.23 | $365K | View |
| Feb 2, 2026 | Bought | ZBIO | 57,000 | $17.96 | $1.0M | View |
| Jan 9, 2026 | Bought | ZBIO | 20,000 | $16.55 | $331K | View |
| Jan 8, 2026 | Bought | ZBIO | 30,000 | $16.30 | $489K | View |
| Jan 7, 2026 | Bought | ZBIO | 50,000 | $16.38 | $819K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1166 | Sudhir Srivastava Chairman and CEO, SS Innovations International. Fort Lauderdale, FL | $139M |
| 1167 | William Austin Musselman Jr. Director, Brown-Forman. Louisville, KY | $138M |
| 1168 | Srinivasan Sivaram President, Tech & Strategy, Western Digital. San Jose, CA | $138M |
| 1169 | Leon O. Moulder Jr. Director, Dianthus Therapeutics. Cambridge, MA | $138M |
| 1170 | Kevin J. Jacobs See Remarks, Hilton Worldwide Holdings. Mclean, VA | $138M |
| 1171 | Scott W. Hart Chief Executive Officer, StepStone Group. New York, NY | $138M |
| 1172 | Harry L. You Director, IonQ. Las Vegas, NV | $137M |
Other Dianthus Therapeutics insiders
All DNTH insiders- Jason Gardner$80.2MSee Remarks. #1789 overall
- Marino Garcia$5.5MCEO AND PRESIDENT. #13487 overall
Questions
How much stock does Leon O. Moulder Jr. own?
Leon O. Moulder Jr. holds $137,908,442 in listed stock based on SEC filings and current prices, mostly Dianthus Therapeutics (DNTH). That ranks 1169th on the Stock Rich List.
Is this Leon O. Moulder Jr.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Leon O. Moulder Jr. last buy or sell stock?
The most recent open-market trade on file is a purchase of 60,000 ZBIO shares on May 18, 2026 at $16.88.